EAM Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

EAM Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,796	Closed	-$1.13M	–	395
2015 Q2	$1.13M	Sell	9,796 -1,997	-17%	-$210K	0.13%	289
2015 Q1	$1.13M	Sell	11,793 -3,375	-22%	-$252K	0.13%	292
2014 Q4	$1.02M	Sell	15,168 -2,305	-13%	-$143K	0.14%	288
2014 Q3	$943K	Hold	17,473	–	–	0.19%	266
2014 Q2	$777K	Buy	+17,473	New	+$714K	0.15%	307

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EAM Investors's CBPO Position: Q3 2015 in Review

EAM Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2015, closing a stake of 9,796 shares — an estimated $1.13M sold.

EAM Investors first reported a position in CBPO in Q2 2014 and held it in 5 quarters. The position peaked at $1.13M in Q2 2015. 106 funds tracked by Wall St. Rank hold CBPO as of Q3 2015.

EAM Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
EAM Investors sold 9,796 China Biologic Products Holdings, Inc. shares in Q3 2015, an estimated $1.13M.
EAM Investors first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 5 quarters.
EAM Investors's China Biologic Products Holdings, Inc. position peaked at $1.13M in Q2 2015.
106 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2015.

Based on EAM Investors's 13F filing for Q3 2015, filed 6 Nov 2015.